Keywords: Adventrx. Poloxamer-based therapeutics, M&A, Financing, Exelbine

ADVENTRX pens deal to buy unnamed poloxamer-based therapeutics firm; sells shares

Article | 10 January 2011

Print This

San Diego, USA-based ADVENTRX Pharmaceuticals (NYSE Amex: ANX) says that it has signed a term sheet to acquire a private ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in